| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
|
Clin Cancer Res
|
2005
|
3.38
|
|
2
|
BRAF mutations in metastatic melanoma: a possible association with clinical outcome.
|
Clin Cancer Res
|
2003
|
3.21
|
|
3
|
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
|
Hum Pathol
|
2008
|
1.25
|
|
4
|
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.
|
Int J Cancer
|
2002
|
1.17
|
|
5
|
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
|
Anticancer Res
|
2009
|
1.06
|
|
6
|
Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma.
|
Melanoma Res
|
2004
|
1.05
|
|
7
|
Diagnosis delay in Libyan female breast cancer.
|
BMC Res Notes
|
2012
|
1.05
|
|
8
|
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
|
Cancer Invest
|
2010
|
1.04
|
|
9
|
A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma.
|
Melanoma Res
|
2010
|
1.03
|
|
10
|
Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer.
|
Head Neck
|
2006
|
0.96
|
|
11
|
Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma.
|
Melanoma Res
|
2007
|
0.93
|
|
12
|
A prognostic model and staging for metastatic uveal melanoma.
|
Cancer
|
2003
|
0.89
|
|
13
|
Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response.
|
Oncology
|
2002
|
0.88
|
|
14
|
Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya.
|
J Cancer
|
2012
|
0.87
|
|
15
|
Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.
|
APMIS
|
2012
|
0.87
|
|
16
|
High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.
|
Anticancer Res
|
2013
|
0.87
|
|
17
|
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
|
J Gastrointest Cancer
|
2009
|
0.86
|
|
18
|
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
|
Melanoma Res
|
2008
|
0.86
|
|
19
|
Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.
|
Tumour Biol
|
2012
|
0.84
|
|
20
|
The association of immunoreactive p53 and Ki-67 with T-stage, grade, occurrence of metastases and survival in renal cell carcinoma.
|
Anticancer Res
|
2006
|
0.83
|
|
21
|
MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases.
|
Scand J Gastroenterol
|
2007
|
0.83
|
|
22
|
Current and predicted cost of metastatic renal cell carcinoma in Finland.
|
Acta Oncol
|
2010
|
0.83
|
|
23
|
Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
|
Melanoma Res
|
2005
|
0.83
|
|
24
|
Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
|
Acta Oncol
|
2012
|
0.82
|
|
25
|
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.
|
Int J Cancer
|
2011
|
0.82
|
|
26
|
Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer.
|
Hum Pathol
|
2010
|
0.81
|
|
27
|
Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
|
Anticancer Res
|
2011
|
0.81
|
|
28
|
Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.
|
Scand J Gastroenterol
|
2007
|
0.79
|
|
29
|
Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.
|
Melanoma Res
|
2005
|
0.79
|
|
30
|
Up-regulation of alpha-catenin is associated with increased lymph node involvement in colorectal cancer.
|
World J Gastroenterol
|
2008
|
0.79
|
|
31
|
NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer.
|
Cancer Chemother Pharmacol
|
2010
|
0.78
|
|
32
|
Randomized, controlled trial of the effect of e-feedback on knowledge about radiotherapy of breast cancer patients in Finland.
|
Nurs Health Sci
|
2014
|
0.78
|
|
33
|
Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival.
|
PLoS One
|
2012
|
0.78
|
|
34
|
Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.
|
Anticancer Res
|
2006
|
0.78
|
|
35
|
Children of parents with cancer: a collaborative project between a child psychiatry clinic and an adult oncology clinic.
|
Clin Child Psychol Psychiatry
|
2007
|
0.78
|
|
36
|
Prognostic significance of DNA image cytometry in Libyan breast cancer.
|
Oncology
|
2012
|
0.77
|
|
37
|
Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.
|
Melanoma Res
|
2011
|
0.76
|
|
38
|
Prognostic value of bcl-2 expression among women with breast cancer in Libya.
|
Tumour Biol
|
2013
|
0.76
|
|
39
|
Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.
|
Oncol Rep
|
2008
|
0.76
|
|
40
|
The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.
|
Virchows Arch
|
2010
|
0.76
|
|
41
|
Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
|
Acta Oncol
|
2009
|
0.76
|
|
42
|
Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer.
|
Anticancer Res
|
2012
|
0.75
|
|
43
|
Nuclear area is a prognostic determinant in advanced colorectal cancer.
|
Anticancer Res
|
2005
|
0.75
|
|
44
|
Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: a randomized controlled trial.
|
Psychooncology
|
2014
|
0.75
|
|
45
|
[Not Available].
|
Duodecim
|
2006
|
0.75
|
|
46
|
[Not Available].
|
Duodecim
|
2007
|
0.75
|
|
47
|
[Prognostic factors and improving treatment of cutaneous melanoma].
|
Duodecim
|
2004
|
0.75
|
|
48
|
[Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku].
|
Duodecim
|
2005
|
0.75
|
|
49
|
[Not Available].
|
Duodecim
|
2006
|
0.75
|
|
50
|
Internet knowledge expectations by radiotherapy patients.
|
Cancer Nurs
|
2008
|
0.75
|
|
51
|
[Not Available].
|
Duodecim
|
2007
|
0.75
|
|
52
|
[Are immunological treatments beneficial for malignant melanoma of the skin?].
|
Duodecim
|
2010
|
0.75
|
|
53
|
Treatment of squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx--an analysis of 174 patients in south western Finland.
|
Acta Oncol
|
2003
|
0.75
|
|
54
|
Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.
|
Cancer Immunol Immunother
|
2014
|
0.75
|